Madrigal Pharmaceuticals
Last updated: August 31, 2025
Madrigal leaders: Drs. Paul Friedman and Rebecca Taub
Country: USA | Funding: $1.9B (+) | Add Funding
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
Website: http://madrigalpharma.com/
The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease.
